Approval of experimental application of Bangavax vaccine in human body under 10 conditions In the country, 3 people died of corona in 24 hours from 8 am on Monday to 8 am on Tuesday. At this time 264 new patients have been identified.

This information has been given in the press release of the health department this afternoon. Earlier in the day, the health department had given information about the deaths of 2 people and the identification of 264 patients in the country.

In the last 24 hours, a total of 19,057 samples were tested in the country. In contrast to the test, the patient identification rate stood at 1.45 percent. On the previous day, the rate was 1.42 percent.

The first corona outbreak occurred in the country in March last year. Since then, the total number of identified patients in the country is 15 lakh 74 thousand 738. Among them 26 thousand 958 people died. 15 lakh 36 thousand 855 people have recovered. In the last 24 hours, 316 people have recovered.

Within a few months

The last three people killed were two men and a woman. One of them is from Dhaka division and two from Chittagong division. No one was killed in the last 24 hours in the remaining six divisions.

The first corona infection occurred in December 2019 in Wuhan, China. Within a few months, the virus spread around the world. The first corona infection was detected in Bangladesh on March 8 last year. The first death was reported on March 17 of the same year.

Different times:

 

Since then the corona infection has been less at different times. However, towards the end of May this year, the situation in the country began to deteriorate due to the corona delta type. Corona’s mass vaccination began in early August. Then both infection and death began to decline. Last Saturday’s bulletin reported that no one was killed in the country in 24 hours.

The Bangladesh Medical Research Council (BMRC) has approved in principle the first-stage experimental application of corona vaccine Bangavax in human body made by Bangladeshi company Globe Biotech. Today, Tuesday, the director of the Bangladesh Medical Research Council. Ruhul Amin has given this information in a letter.

3 people died in Corona

The Globe Biotech vaccine was tested on monkeys from August to September. The results obtained there they submit to the BMRC and apply for application to the human body. The BMRC has since approved the experimental application of the vaccine’s effectiveness in the human body.

A BMRC researcher told Prothom Alo that Globe Biotech has been approved for experimental application of Bangavax on 10 conditions. One of these is to ensure the rights and well-being of those who voluntarily take the vaccine, and to ensure that those who do take it knowingly survive.

Globe Biotech announced at a press conference in July last year that it had invented the coronary antidote Bangavax vaccine. Since then, the company has been trying to get approval for the trial application of the vaccine.